uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted April 06, 2016

FDA Warns of Stimulant Methylsynephrine In Supplements

On March 31, 2016, the FDA issued warning letters to seven companies selling products containing methylsynephrine (also called p-hydroxyephedrine or Oxilofrine), a stimulant drug which is not permitted in dietary supplements in the U.S.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at